{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:54:36Z","timestamp":1790952876292,"version":"4.1.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"20","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["J Am Acad Orthop Surg","JAAOS"],"published-print":{"date-parts":[[2026,10,15]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Celecoxib is commonly used for postoperative analgesia because of its favorable adverse effect profile compared with other nonsteroidal anti-inflammatory drugs. However, its use is often restricted in patients labeled as sulfonamide (\u201csulfa\u201d) allergic due to persistent electronic health record warnings, despite contemporary evidence showing minimal risk of immunologic cross-reactivity. The purpose of this study was to evaluate the safety of postoperative celecoxib administration in orthopaedic patients with documented sulfonamide allergies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A retrospective cohort study was conducted at a single tertiary academic center. Orthopaedic surgery patients from January 1, 2020, to December 31, 2022, with a documented sulfonamide allergy who received celecoxib postoperatively were included. All postoperative clinic notes, telephone encounters, and emergency department records from surgery through the second follow-up visit were reviewed to identify allergic reactions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Sixty-one patients met inclusion criteria (mean age, 52.6 \u00b1 15.7 years; 67.2% female). The mean time to the first and second postoperative visits was 17 \u00b1 7 and 49 \u00b1 19 days, respectively. Thirteen patients (21.3%) presented to the emergency department during follow-up for issues, including postoperative pain or swelling, gastrointestinal complaints, constipation, unrelated trauma, or noncardiac chest pain. Two patients experienced allergic reactions attributed to perioperative antibiotics or surgical adhesive. One patient (1.6%) sustained a gastrointestinal bleed while also taking aspirin for thromboprophylaxis. No allergic reactions were attributable to celecoxib.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Celecoxib was safely administered to patients with documented sulfonamide allergies, with no evidence of cross-reactivity. Given its analgesic benefits and overall safety profile, routine avoidance of celecoxib in sulfa-allergic patients appears unnecessary. Updating electronic health record decision-support logic to reflect current evidence may reduce alert fatigue and support more effective multimodal pain management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5435\/jaaos-d-25-01556","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T13:00:34Z","timestamp":1780059634000},"page":"e2971-e2976","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Safety of Celecoxib in Postoperative Patients With Documented Sulfonamide Allergies"],"prefix":"10.5435","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-1195-8780","authenticated-orcid":false,"given":"Josiah","family":"Snowden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catharina","family":"Gaeth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Penner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Kshir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Fellows","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8507-6001","authenticated-orcid":false,"given":"Daniel J.","family":"Cognetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"R1-20261002","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1471-2474-9-77","article-title":"Perioperative celecoxib administration for pain management after total knee arthroplasty \u2013 A randomized, controlled study","volume":"9","author":"Huang","year":"2008","journal-title":"BMC Musculoskelet Disord"},{"key":"R2-20261002","doi-asserted-by":"crossref","first-page":"6386","DOI":"10.3390\/jcm11216386","article-title":"Multimodal pain management in orthopedic surgery","volume":"11","author":"Chunduri","year":"2022","journal-title":"J Clin Med"},{"key":"R3-20261002","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1001\/jama.2022.16844","article-title":"Effect of a postoperative multimodal opioid-sparing protocol vs standard opioid prescribing on postoperative opioid consumption after knee or shoulder arthroscopy: A randomized clinical trial","volume":"328","author":"Gazendam","year":"2022","journal-title":"JAMA"},{"key":"R4-20261002","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/FPC.0b013e32834f94cb","article-title":"Celecoxib pathways: Pharmacokinetics and pharmacodynamics","volume":"22","author":"Gong","year":"2012","journal-title":"Pharmacogenet Genomics"},{"key":"R5-20261002","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1001\/jama.284.10.1247","article-title":"Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid ArthritisThe CLASS study: A randomized controlled trial","volume":"284","author":"Silverstein","year":"2000","journal-title":"JAMA"},{"key":"R6-20261002","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.jamcollsurg.2021.01.005","article-title":"Systematic review and meta\u2013analysis of the association between non\u2013steroidal anti\u2013inflammatory drugs and operative bleeding in the perioperative period","volume":"232","author":"Bongiovanni","year":"2021","journal-title":"J Am Coll Surg"},{"key":"R7-20261002","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1073\/pnas.96.1.272","article-title":"Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: The human pharmacology of a selective inhibitor of COX-2","volume":"96","author":"McAdam","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R8-20261002","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3390\/pharmacy7030132","article-title":"Sulfonamide allergies","volume":"7","author":"Giles","year":"2019","journal-title":"Pharmacy"},{"key":"R9-20261002","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2165\/00002018-200326030-00004","article-title":"Safety of celecoxib in individuals allergic to sulfonamide","volume":"26","author":"Shapiro","year":"2003","journal-title":"Drug Saf"},{"key":"R10-20261002","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1056\/NEJMoa022963","article-title":"Absence of cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics","volume":"349","author":"Strom","year":"2003","journal-title":"N Engl J Med"},{"key":"R11-20261002","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.iac.2004.03.011","article-title":"Sulfonamide hypersensitivity","volume":"24","author":"Slatore","year":"2004","journal-title":"Immunol Allergy Clin North Am"},{"key":"R12-20261002","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S1081-1206(10)60415-2","article-title":"Allergies to sulfonamide antibiotics and sulfur-containing drugs","volume":"100","author":"Dibbern","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R13-20261002","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1016\/j.jaip.2019.05.034","article-title":"Sulfonamide hypersensitivity: Fact and fiction","volume":"7","author":"Khan","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R14-20261002","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/jamia\/ocv143","article-title":"Rising drug allergy alert overrides in electronic health records: An observational retrospective study of a decade of experience","volume":"23","author":"Topaz","year":"2016","journal-title":"J Am Med Inform Assoc"},{"key":"R15-20261002","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1093\/jamia\/ocz095","article-title":"Medication safety alert fatigue may be reduced via interaction design and clinical role tailoring: A systematic review","volume":"26","author":"Hussain","year":"2019","journal-title":"J Am Med Inform Assoc"},{"key":"R16-20261002","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1136\/bmjqs-2015-004851","article-title":"A cross-sectional observational study of high override rates of drug allergy alerts in inpatient and outpatient settings, and opportunities for improvement","volume":"26","author":"Slight","year":"2017","journal-title":"BMJ Qual Saf"},{"key":"R17-20261002","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1345\/aph.1E350","article-title":"Sulfonamide cross-reactivity: Fact or fiction?","volume":"39","author":"Johnson","year":"2005","journal-title":"Ann Pharmacother"},{"key":"R18-20261002","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11882-007-0029-8","article-title":"Sulfonamide allergy and cross-reactivity","volume":"7","author":"Brackett","year":"2007","journal-title":"Curr Allergy Asthma Rep"},{"key":"R19-20261002","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/S0149-2918(00)87238-0","article-title":"Immunologic tolerability profile of celecoxib","volume":"21","author":"Patterson","year":"1999","journal-title":"Clin Ther"},{"key":"R20-20261002","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1592\/phco.26.4.551","article-title":"Sulfonamide allergies and outcomes related to use of potentially cross-reactive drugs in hospitalized patients","volume":"26","author":"Hemstreet","year":"2006","journal-title":"Pharmacotherapy"},{"key":"R21-20261002","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.2146\/ajhp120291","article-title":"Sulfonamide cross-reactivity: Is there evidence to support broad cross-allergenicity?","volume":"70","author":"Wulf","year":"2013","journal-title":"Am J Health Syst Pharm"},{"key":"R23-20261002","doi-asserted-by":"crossref","first-page":"791513","DOI":"10.3389\/fsurg.2022.791513","article-title":"The efficacy and safety of celecoxib for pain management after total knee arthroplasty: A systematic review and meta-analysis of randomized controlled trials","volume":"9","author":"Geng","year":"2022","journal-title":"Front Surg"},{"key":"R24-20261002","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1592\/phco.24.9.856.36106","article-title":"Likelihood and mechanisms of cross-allergenicity between sulfonamide antibiotics and other drugs containing a sulfonamide functional group","volume":"24","author":"Brackett","year":"2004","journal-title":"Pharmacotherapy"},{"key":"R25-20261002","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1197\/jamia.M1809","article-title":"Overriding of drug safety alerts in computerized physician order entry","volume":"13","author":"van der Sijs","year":"2006","journal-title":"J Am Med Inform Assoc"},{"key":"R26-20261002","doi-asserted-by":"crossref","first-page":"e138","DOI":"10.1093\/jamia\/ocv144","article-title":"Alert dwell time: Introduction of a measure to evaluate interruptive clinical decision support alerts","volume":"23","author":"McDaniel","year":"2016","journal-title":"J Am Med Inform Assoc"},{"key":"R27-20261002","first-page":"1","article-title":"Reducing alert burden in electronic health records: State of the art recommendations from four health systems","volume":"11","author":"McGreevey","year":"2020","journal-title":"Appl Clin Inform"}],"container-title":["Journal of the American Academy of Orthopaedic Surgeons"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.5435\/JAAOS-D-25-01556","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:00:20Z","timestamp":1790949620000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.5435\/JAAOS-D-25-01556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":26,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.5435\/jaaos-d-25-01556","relation":{},"ISSN":["1067-151X","1940-5480"],"issn-type":[{"value":"1067-151X","type":"print"},{"value":"1940-5480","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"assertion":[{"value":"2025-12-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-04","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}